Про Symbiotix biotherapies, inc.

Про компанію

Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.The company's novel class of molecular therapeutics include a novel class of Treg-modulating therapeutics based on molecules derived from the human microbiom, enabling patients access first-in-class oral agents that improves their lives and helps them to treat themselves of inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases.